These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11760925)

  • 1. A comparative study on schizophrenic patients with dual diagnosis.
    Modestin J; Gladen CJ; Christen S
    J Addict Dis; 2001; 20(4):41-51. PubMed ID: 11760925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings.
    Thoma P; Daum I
    Psychiatry Clin Neurosci; 2013 Sep; 67(6):367-83. PubMed ID: 23890122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in substance abuse patterns: multiple drug abuse alone versus schizophrenia with multiple drug abuse.
    Lammertink M; Löhrer F; Kaiser R; Hambrecht M; Pukrop R
    Acta Psychiatr Scand; 2001 Nov; 104(5):361-6. PubMed ID: 11722317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug abuse in schizophrenic patients: clinical correlates and reasons for use.
    Dixon L; Haas G; Weiden PJ; Sweeney J; Frances AJ
    Am J Psychiatry; 1991 Feb; 148(2):224-30. PubMed ID: 1987823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Courses of substance use and schizophrenia in the dual-diagnosis patients: is there a relationship?
    Goswami S; Singh G; Mattoo SK; Basu D
    Indian J Med Sci; 2003 Aug; 57(8):338-46. PubMed ID: 12944690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of potentially abusive psychotropic substances in psychiatric inpatients.
    Modestin J; Nussbaumer C; Angst K; Scheidegger P; Hell D
    Eur Arch Psychiatry Clin Neurosci; 1997; 247(3):146-53. PubMed ID: 9224907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dual diagnosis in psychiatric inpatients: prevalence and general characteristics].
    Rodríguez-Jiménez R; Aragüés M; Jiménez-Arriero MA; Ponce G; Muñoz A; Bagney A; Hoenicka J; Palomo T
    Invest Clin; 2008 Jun; 49(2):195-205. PubMed ID: 18717266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders.
    San L; Arranz B; Martinez-Raga J
    Eur Addict Res; 2007; 13(4):230-43. PubMed ID: 17851245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia.
    Krystal JH; D'Souza DC; Gallinat J; Driesen N; Abi-Dargham A; Petrakis I; Heinz A; Pearlson G
    Neurotox Res; 2006 Dec; 10(3-4):235-52. PubMed ID: 17197373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of substance abuse in schizophrenia: nature and significance.
    DeQuardo JR; Carpenter CF; Tandon R
    J Psychiatr Res; 1994; 28(3):267-75. PubMed ID: 7932286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of patterns of substance abuse among patients with schizophrenia.
    Cuffel BJ; Heithoff KA; Lawson W
    Hosp Community Psychiatry; 1993 Mar; 44(3):247-51. PubMed ID: 8444435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Schizophrenia and substance dependence].
    Uchtenhagen A
    Schweiz Arch Neurol Psychiatr (1985); 1995; 146(5):215-23. PubMed ID: 8658102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
    Potvin S; Stip E; Roy JY
    Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues.
    Coulston CM; Perdices M; Tennant CC
    Aust N Z J Psychiatry; 2007 Nov; 41(11):869-84. PubMed ID: 17924240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between symptoms of schizophrenia and substance abuse.
    Brunette MF; Mueser KT; Xie H; Drake RE
    J Nerv Ment Dis; 1997 Jan; 185(1):13-20. PubMed ID: 9040528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis and schizophrenia: results of a follow-up study.
    Caspari D
    Eur Arch Psychiatry Clin Neurosci; 1999; 249(1):45-9. PubMed ID: 10195343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.
    Potvin S; Stip E; Lipp O; Roy MA; Demers MF; Bouchard RH; Gendron A
    Am J Drug Alcohol Abuse; 2008; 34(1):75-82. PubMed ID: 18161645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.